Autoimmune Encephalitis

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Refractory Neurologic Autoimmune Disease

A Basket Study of CTA313 in Participants With Active Autoimmune Diseases

Biomarkers in Autoimmune Disease of Nervous System

Relapse and Functional Outcomes in Anti-LGI1 Encephalitis

Cohort Study on Neuroimmune Diseases in the Reproductive Age

IVIG and Rituximab in Antibody-associated Psychosis - SINAPPS2

A Study in Participants With Anti-NMDAR Encephalitis and Anti-NMDAR Autoantibody-Associated Psychiatric Disease

Phase 1 Study of ART5803 in Healthy Participants

Phase 1 Study of ART5803 Safety and PK After IVIG in Healthy Participants

FDG-PET in the Diagnosis of Autoimmune Encephalitis

Study of Pathogenic Mechanisms and Identification of Novel Autoantibodies in Autoimmune Encephalitis

Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research

Tongji NADs Cohort

A Study of C-CAR168 in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy

Long-term Impact of NMDAR Encephalitis

Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases

Monitoring of Outcomes of Cellular and Exosome-based Therapies in Autoinflammatory and Post-infectious Neuroinflammatory Syndromes

Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis

A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis

Impact of Confirmed Autoimmune Encephalitis on Brain Glucose Metabolism